Weight loss · Cleveland area, OH
Weight loss and obesity studies in Cleveland area, OH
7 recruiting studies have a site in the Cleveland area. This page includes nearby cities such as Beachwood, Mayfield Heights, Independence, Westlake.
7 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 3
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Eli Lilly and Company
- Location
- Westlake, OH + 36 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 3
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Eli Lilly and Company
- Location
- Westlake, OH + 34 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingHealthy volunteers
Comparing Reduction With ESD- Versus APC-TORe
Stephen Firkins
- Location
- Cleveland, OH
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersPhase 4
Fibrosis Lessens After Metabolic Surgery
The Cleveland Clinic
- Location
- Cleveland, OH
- Eligibility basics
- Ages 18–75
- RecruitingHealthy volunteers
CV Imaging of Metabolic Interventions
The Cleveland Clinic
- Location
- Cleveland, OH
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteers
Preoperative Weight Loss for Open Abdominal Wall Reconstruction
Benjamin T. Miller
- Location
- Cleveland, OH + 1 other US site
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteers
Effects of Assisted Robotic vs Laparoscopic Sleeve Gastrectomy
Ricard Corcelles
- Location
- Cleveland, OH
- Eligibility basics
- Ages 18–70
Who these studies look for
Most of these studies set a BMI range and may exclude people taking certain weight-loss medicines or who have had bariatric surgery. Some require a weight-related condition such as type 2 diabetes or high blood pressure.
Matching a page like this one never means you qualify. Each research team decides eligibility at screening.